UHS shows durable top-line expansion, with revenue growing from $3.9B in 2024Q2 to roughly $4.6B in 2026Q2 and quarterly operating cash flow running 1.02x to 2.35x net income, which suggests earnings are backed by real cash generation.
Price trend, volume and key moving averages
Start with the evidence for owning the stock and the risks that can break the thesis.
Revenue grew steadily from $3.9B in 2024Q2 to $4.7B in 2026Q3 while operating margin held in a narrow 9.6% to 11.7% band, yet diluted EPS swung from $3.80 to $7.01, suggesting below-the-line items drive much of the earnings variability.
UHS has above-consensus 2026 guidance, indicating a strong near-term earnings trajectory despite recent quarterly misses.
The bullish case hinges on UHS's ability to grow earnings by expanding acute and behavioral healthcare capacity.
Recent quarterly results showed strong revenue growth, margin expansion, and disciplined capital allocation.
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Oct 27, 2026 | $5.22+0.6% vs $5.19 | $4.7B+0.5% vs $4.7B |
Q3 2026 Jul 27, 2026 | $5.98+0.7% vs $5.94 | $4.6B+1.3% vs $4.6B |
Q2 2026 Apr 27, 2026 | $5.62+3.9% vs $5.41 | $4.5B+2.5% vs $4.4B |
Q1 2026 Feb 25, 2026 | $5.88-0.7% vs $5.92 | $4.5B-0.4% vs $4.5B |
KING OF PRUSSIA, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the UBS Global Healthcare Conference on November 10, 2026, at 9:30 a.m.
Universal Health Services NYSE: UHS reported third-quarter adjusted earnings per share of $5.22, down 8% from a year earlier, as the company cited favorable acute-care demand, improving behavioral-health volumes and moderating labor pressures but said results fell below its internal expectations after excluding certain items.
Universal Health Services' Q3 earnings fall 8.3% despite revenue growth, as rising costs and Acute Care pricing pressure offset higher patient volumes.
Universal Health Services, Inc. ( UHS ) Q3 2026 Earnings Call October 28, 2026 8:00 AM EDT Company Participants Darren Lehrich - Vice President of Investor Relations Marc Miller - CEO, President & Director Steve Filton - Executive VP, CFO & Secretary Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Justin Lake - Wolfe Research, LLC Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Kevin Fischbeck - BofA Securities, Research Division Craig Hettenbach - Morgan Stanley, Research Division Jason Cassorla - Guggenheim Securities, LLC, Research Division Andrew Mok - Barclays Bank PLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Presentation Operator Good day, and thank you for standing by. Welcome to the Q3 2026 Universal Health Services Earnings Conference Call.
Benchmark UHS against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Universal Health Services, Inc. (UHS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $195.50 | $11.83B | 7.91 | 9.71% | 7.96% | 19.27% | 0.41% | |
| $494.99 | $107.17B | 15.87 | 7.08% | 8.61% | — | 0.59% | |
| $283.33 | $24.41B | 7.88 | 3.12% | 12.71% | 32.11% | — | |
| $2.21 | $311.63M | -0.58 | -1.18% | -2.34% | — | — | |
| $181.08 | $10.55B | 26.91 | 18.72% | 7.03% | 16.61% | 0.14% | |
| $37.00 | $3.44B | -3.01 | 5.04% | -33.07% | -51.55% | — |
Universal Health Services, Inc. (UHS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Universal Health Services, Inc. (UHS) SEC filings — annual & quarterly reports (10-K, 10-Q)
Oct 27, 2026·SEC
Aug 21, 2026·SEC
Aug 17, 2026·SEC
Get notified when UHS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Universal Health Services, Inc. (UHS) stock FAQ — growth, dividends, profitability & financials explained
Universal Health Services, Inc. (UHS) reported $18.35B in revenue over the trailing twelve months. Revenue was $17.36B in fiscal year 2025. That is 1359% more than the $1.19B of fiscal year 1996.
Universal Health Services, Inc. (UHS) grew revenue by 8.0% over the trailing twelve months, compared with the twelve months before.
Yes. Universal Health Services, Inc. (UHS) earned $1.46B in net income over the trailing twelve months (a 8.0% net margin).
Yes. Universal Health Services, Inc. (UHS) pays a dividend that yields 0.41% at the current price, a small yield.
Universal Health Services, Inc. (UHS) had a return on equity (ROE) of 19.3% over the trailing twelve months. That is above the market's typical 10-15%.
Universal Health Services, Inc. (UHS) generated $1.12B in free cash flow over the trailing twelve months.
